Clinical Trial Update: Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops [NA]

View source ↗

Summary

The Vanderbilt-sponsored clinical trial on refractory Eustachian Tube Dysfunction, potentially related to endolymphatic hydrops, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endolymphatic Hydrops
• Eustachian Tube Dysfunction

Snippet

Sponsor: Vanderbilt University | Conditions: Eustachian Tube Dysfunction, Endolymphatic Hydrops | NA | Status: WITHDRAWN